These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

39 related items for PubMed ID: 3104183

  • 1. Effects of dopaminergic agonists on plasma luteinizing hormone-releasing hormone (LRH) and gonadotropins in man.
    Matsubara M, Tango M, Nakagawa K.
    Horm Metab Res; 1987 Jan; 19(1):31-4. PubMed ID: 3104183
    [Abstract] [Full Text] [Related]

  • 2. The effect of L-dopa and clomiphene citrate on peripheral plasma levels of luteinizing hormone-releasing factor.
    Polansky S, Muechler E, Sorrentino S.
    Obstet Gynecol; 1976 Jul; 48(1):79-83. PubMed ID: 778710
    [Abstract] [Full Text] [Related]

  • 3. Analysis of clinical studies with natural and synthetic luteinizing hormone-releasing hormone in man.
    Kastin AJ, Schally AV, Zarate A, Arimura A, Gonzalez-Barcena D, Medeiros-Neto CA, Schalch DS.
    Isr J Med Sci; 1974 Oct; 10(10):1305-13. PubMed ID: 4611964
    [Abstract] [Full Text] [Related]

  • 4. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
    Tresguerres JA, Esquifino AI.
    Acta Physiol Lat Am; 1983 Oct; 33(3):257-74. PubMed ID: 6424409
    [Abstract] [Full Text] [Related]

  • 5. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.
    Bagatell CJ, Dahl KD, Bremner WJ.
    J Androl; 1994 Oct; 15(1):15-21. PubMed ID: 8188534
    [Abstract] [Full Text] [Related]

  • 6. The effect of luteinizing hormone releasing hormone (LRH) on pituitary gonadotropins in male homosexuals.
    Livingstone IR, Sagel J, Distiller LA, Morley J, Katz M.
    Horm Metab Res; 1978 May; 10(3):248-9. PubMed ID: 352888
    [Abstract] [Full Text] [Related]

  • 7. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I, Ambrosi F, Giammartino C, Fedeli L, Mannarelli C, Filipponi P.
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [Abstract] [Full Text] [Related]

  • 8. Effects of continuous LHRH infusion on plasma levels of LH and FSH in males, before and after oestrogen or anti-oestrogen treatment.
    van Bergeijk L, Gooren LJ, van Kessel H, Sassen AM.
    Horm Metab Res; 1986 Aug; 18(8):558-64. PubMed ID: 3093351
    [Abstract] [Full Text] [Related]

  • 9. Effects of increased central dopaminergic tonus on gonadotropin secretion.
    Travaglini P, Montanari C, Ballabio M, Elli R, Scaperrotta RC, Faglia G.
    J Endocrinol Invest; 1981 Aug; 4(2):237-40. PubMed ID: 6792267
    [Abstract] [Full Text] [Related]

  • 10. Effect of dexamethsone on luteinizing hormone and follicle stimulating hormone responses to LHRH and to clomiphene in the follicular phase of women with normal menstrual cycles.
    Sowers JR, Rice BF, Blanchard S.
    Horm Metab Res; 1979 Aug; 11(8):478-80. PubMed ID: 387565
    [Abstract] [Full Text] [Related]

  • 11. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ, Bergquist C, Wide L.
    Int J Fertil; 1980 Aug; 25(3):239-46. PubMed ID: 6108935
    [Abstract] [Full Text] [Related]

  • 12. Effect of quinestrol on plasma and urinary gonadotropins of postmenopausal women.
    Ricciardi I, Bruni G, Imparato E, Marino L, Pesando P.
    Horm Metab Res; 1975 Jul; 7(4):323-6. PubMed ID: 1150131
    [Abstract] [Full Text] [Related]

  • 13. Evidence for altered catecholamine metabolism in polycystic ovary syndrome.
    Shoupe D, Lobo RA.
    Am J Obstet Gynecol; 1984 Nov 01; 150(5 Pt 1):566-71. PubMed ID: 6437227
    [Abstract] [Full Text] [Related]

  • 14. Oxytocin levels and disappearance rate and plasma follicle-stimulating hormone and luteinizing hormone after oxytocin infusion in men.
    Dawood MY, Ylikorkala O, Trivedi D, Gupta R.
    J Clin Endocrinol Metab; 1980 Feb 01; 50(2):397-400. PubMed ID: 7354123
    [Abstract] [Full Text] [Related]

  • 15. Central nervous system and pituitary mechanisms in dopaminergic stimulation of growth hormone release in women.
    Ferrari C, Caldara R, Barbieri C, Testori GP, Benco R, Trezzi R, Crossignani RM, Rampini P.
    Neuroendocrinology; 1981 Apr 01; 32(4):213-6. PubMed ID: 7219673
    [Abstract] [Full Text] [Related]

  • 16. L-DOPA effects on sexual behaviour: an experimental study.
    Keyes DM, Janzik HH, Mayer K, Eichner M, Gupta D.
    J Sex Res; 1976 May 01; 12(2):117-23. PubMed ID: 950778
    [No Abstract] [Full Text] [Related]

  • 17. Plasma LRH levels in chronic renal failure before and during haemodialysis.
    Matsubara M, Nakagawa K, Nonomura K, Hirota N.
    Acta Endocrinol (Copenh); 1983 Jun 01; 103(2):145-50. PubMed ID: 6344528
    [Abstract] [Full Text] [Related]

  • 18. Alterations in the spermatogenic pattern after L-dopa.
    Joseph T, Thomas JA, Murthy DK, Reddy KS.
    Indian J Med Res; 1980 Jan 01; 71():46-52. PubMed ID: 6769794
    [No Abstract] [Full Text] [Related]

  • 19. The effect of central and peripheral dopamine-agonists on ventilation in the mouse.
    Olson LG, Saunders NA.
    Respir Physiol; 1985 Sep 01; 61(3):335-45. PubMed ID: 4059691
    [Abstract] [Full Text] [Related]

  • 20. Evidence for dopamine as an inhibitor of vasoprotein release in man.
    Lightman SL, Forsling M.
    Clin Endocrinol (Oxf); 1980 Jan 01; 12(1):39-46. PubMed ID: 7379312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.